Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 52

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 2
Chunk 52
---
 the Nine months ended September 30, 2025 and 2024

The
following table shows a summary of our cash flows for the nine months ended September 30, 2025 and 2024.

    For
    the Nine months ended 
September 30, 

    2025  
    2024 
  
    Net
    cash flows from operating activities 
    $(3,045,713) 
    $(215,225)
  
    Net
    cash flows from investing activities 
     -  
     - 
  
    Net
    cash flows from financing activities 
    $-  
    $187,000 
  
    Net
    increase (decrease) in cash 
    $(3,045,713) 
    $(28,225)

Net
Cash Flows From Operating Activities:

Net
cash used in operating activities during the nine months ended September 30, 2025 was $3,045,713, as compared to net cash used in
operating activities of $215,225 for the nine months ended September 30, 2024. The increase in net cash used in operating activities
was primarily attributable to the significant increase in net loss, which totaled $6,069,866 in 2025 compared to $911,998 in 2024.
The higher net loss was partially offset by increased non-cash adjustments, including $1,955,275 of stock-based compensation in 2025
compared to $827,357 in 2024 and $573,424 of non -cash amortization of prepaid contracts in 2025 compared to no comparable
amortization in 2024. Additionally, the prior period included a non-cash loss on extinguishment of debt of $951,868 and a gain on
forgiveness of accrued compensation of $40,000, which did not recur in the current period. Changes in working capital also
contributed to the variance, primarily due to an increase in accounts payable and accrued expenses of $81,869 in 2025 compared to
$117,555 in 2024 and an increase of $433,959 in accrued compensation in 2025 versus an increase of $541,135 in 2024.

Net
Cash Flows From Financing Activities:

Net
cash provided by financing activities during the nine months ended September 30, 2025 was $0, as compared to net cash provided in financing
activities of $187,000 for